Bone Disease in Cirrhosis

Overview

Journal Clin Liver Dis (Hoboken)

Specialty Gastroenterology

Date 2019 May 2

PMID 31040999

Citations 16

Authors

Nishita Patel

Santiago J Munoz

Affiliations

Soon will be listed here.

Citing Articles

Prevalent osteoporosis and fracture risk in patients with hepatic cirrhosis: a systematic review and meta-analysis.

Shirinezhad A, Eshlaghi F, Salabat D, Azarboo A, Ardakani Z, Esmaeili S BMC Gastroenterol. 2025; 25(1):115.

PMID: 40000980 PMC: 11853567. DOI: 10.1186/s12876-025-03720-6.

High bone fracture risk in a large modern cohort of liver transplant recipients.

Zavatta G, Vitale G, Morelli M, Pianta P, Turco L, Cappa F Intern Emerg Med. 2024; 20(1):139-150.

PMID: 39331313 PMC: 11794375. DOI: 10.1007/s11739-024-03767-5.

From liver to hormones: The endocrine consequences of cirrhosis.

Quiroz-Aldave J, Gamarra-Osorio E, Durand-Vasquez M, Rafael-Robles L, Gonzales-Yovera J, Quispe-Flores M World J Gastroenterol. 2024; 30(9):1073-1095.

PMID: 38577191 PMC: 10989500. DOI: 10.3748/wjg.v30.i9.1073.

Osteoporosis and Fragility Fractures in Patients with Liver Cirrhosis: Usefulness of FRAX as a Screening Tool.

Sanchez-Delgado J, Profitos J, Arevalo M, Lira A, Marmol C, Miquel M J Clin Med. 2024; 13(1).

PMID: 38202195 PMC: 10780144. DOI: 10.3390/jcm13010188.

Evaluation and Management of Chronic Cholestatic Liver Diseases.

Rini S, Wibawa I Middle East J Dig Dis. 2023; 15(3):148-155.

PMID: 38023462 PMC: 10660321. DOI: 10.34172/mejdd.2023.336.

References

Giannini S, Nobile M, Ciuffreda M, Iemmolo R, Dalle Carbonare L, Minicuci N . Long-term persistence of low bone density in orthotopic liver transplantation. Osteoporos Int. 2000; 11(5):417-24. DOI: 10.1007/s001980070109. View

Carey E, Balan V . Metabolic bone disease in patients with liver disease. Curr Gastroenterol Rep. 2003; 5(1):71-7. DOI: 10.1007/s11894-003-0012-z. View

Kim M, Shim M, Kim M, Lee Y, Shin Y, Chung C . Effect of chronic alcohol ingestion on bone mineral density in males without liver cirrhosis. Korean J Intern Med. 2003; 18(3):174-80. PMC: 4531624. DOI: 10.3904/kjim.2003.18.3.174. View

Sokhi R, Anantharaju A, Kondaveeti R, Creech S, Islam K, Van Thiel D . Bone mineral density among cirrhotic patients awaiting liver transplantation. Liver Transpl. 2004; 10(5):648-53. DOI: 10.1002/lt.20104. View

Zein C, Jorgensen R, Clarke B, Wenger D, Keach J, Angulo P . Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial. Hepatology. 2005; 42(4):762-71. DOI: 10.1002/hep.20866. View

Giouleme O, Vyzantiadis T, Nikolaidis N, Vasiliadis T, Papageorgiou A, Eugenidis N . Pathogenesis of osteoporosis in liver cirrhosis. Hepatogastroenterology. 2006; 53(72):938-43. View

Mounach A, Ouzzif Z, Wariaghli G, Achemlal L, Benbaghdadi I, Aouragh A . Primary biliary cirrhosis and osteoporosis: a case-control study. J Bone Miner Metab. 2008; 26(4):379-84. DOI: 10.1007/s00774-007-0833-1. View

Malik P, Gasser R, Kemmler G, Moncayo R, Finkenstedt G, Kurz M . Low bone mineral density and impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Alcohol Clin Exp Res. 2008; 33(2):375-81. DOI: 10.1111/j.1530-0277.2008.00847.x. View

George J, Ganesh H, Acharya S, Bandgar T, Shivane V, Karvat A . Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol. 2009; 15(28):3516-22. PMC: 2715978. DOI: 10.3748/wjg.15.3516. View

10.

Wariaghli G, Mounach A, Achemlal L, Benbaghdadi I, Aouragh A, Bezza A . Osteoporosis in chronic liver disease: a case-control study. Rheumatol Int. 2009; 30(7):893-9. DOI: 10.1007/s00296-009-1071-8. View

11.

Goral V, Simsek M, Mete N . Hepatic osteodystrophy and liver cirrhosis. World J Gastroenterol. 2010; 16(13):1639-43. PMC: 2848372. DOI: 10.3748/wjg.v16.i13.1639. View

12.

Loria I, Albanese C, Giusto M, Galtieri P, Giannelli V, Lucidi C . Bone disorders in patients with chronic liver disease awaiting liver transplantation. Transplant Proc. 2010; 42(4):1191-3. DOI: 10.1016/j.transproceed.2010.03.096. View

13.

Guanabens N, Pares A, Marinoso L, Brancos M, Piera C, Serrano S . Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol. 1990; 85(10):1356-62. View

14.

Lopez-Larramona G, Lucendo A, Gonzalez-Castillo S, Tenias J . Hepatic osteodystrophy: An important matter for consideration in chronic liver disease. World J Hepatol. 2012; 3(12):300-7. PMC: 3246548. DOI: 10.4254/wjh.v3.i12.300. View

15.

Diamond T, Stiel D, Posen S . Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors?. Ann Intern Med. 1989; 110(6):430-6. DOI: 10.7326/0003-4819-110-6-430. View

16.

Janes C, Dickson E, Okazaki R, Bonde S, McDonagh A, Riggs B . Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest. 1995; 95(6):2581-6. PMC: 295940. DOI: 10.1172/JCI117959. View

17.

Lindor K, Janes C, Crippin J, Jorgensen R, Dickson E . Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?. Hepatology. 1995; 21(2):389-92. View

18.

Camisasca M, Crosignani A, Battezzati P, Albisetti W, GRANDINETTI G, Pietrogrande L . Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis. Hepatology. 1994; 20(3):633-7. View

19.

Gonzalez-Calvin J, Garcia-Sanchez A, Bellot V, Munoz-Torres M, Raya-Alvarez E . Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism. Alcohol Alcohol. 1993; 28(5):571-9. View

20.

Guanabens N, Pares A, Monegal A, Peris P, Pons F, Alvarez L . Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years. Gastroenterology. 1997; 113(1):219-24. DOI: 10.1016/s0016-5085(97)70098-2. View